SCCM Account Access
SCCM recently updated its digital infrastructure. If you have an existing SCCM account, and have not logged in since November 1, 2024, you will need to create an account with the email address associated with your previous SCCM account. Learn more about SCCM account access here.
Some website functionality may be limited as improvements continue. Please ensure you are logged in for the best experience.
Ludwig H. Lin, MD, and Ashish K. Khanna, MD, FCCP, FCCM, discuss Dr. Khanna’s top-rated abstract, Derivation and Validation of a Novel Opioid-Induced Respiratory Depression Risk Prediction Tool (Khanna A, et al. Crit Care Med. 2019;47:18), from the Society of Critical Care Medicine’s 48th Critical Care Congress.
Nearly half of all in-hospital cardiorespiratory arrests occur on general care floors; opioid-induced respiratory depression (OIRD) is one potential cause of these events.
Dr. Khanna investigated the incidence of OIRD as part of the PRODIGY trial. Dr. Khanna is an associate professor of anesthesiology and associate chief of research at Wake Forest University School of Medicine in Winston-Salem, North Carolina, USA.
Dr. Khanna discloses that he served on the executive advisory board for the respiratory monitoring division of Medtronic and received consulting fees from Medtronic for being part of the steering committee of the PRODIGY trial.
This podcast is supported by an unrestricted educational grant provided by Medtronic.
*If you are unable to play the podcast please click here to download the file.
